Back to mobile site

Revance Therapeutic (RVNC) PT Lowered to $40 at Stifel

January 10, 2020 7:08 AM EST
Get Alerts RVNC Hot Sheet
Price: $3.65 --0%

Rating Summary:
    4 Buy, 14 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Stifel analyst Annabel Samimy lowered the price target on Revance Therapeutic (NASDAQ: RVNC) to $40.00 (from $45.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change